UR Through PPL

For the past 20 years, we have helped our clients and payors minimize their exposures to opioid abuse through utilization review, early intervention and education, limited provider/dispensing networks, and the latest science. There is a new opioid control mechanism looming, and it’s called exclusions in Products and Professional Liability (PPL) insurance.

Claire Wilkinson, writing in Business Insurance, explains how these opioid coverage exclusions and restrictions are affecting the manufacturers, distributors and dispensers of opioids. These insurance markets are ever-evolving and are the results of class action litigation, claims trends, and tragedies reported in the press.

It seems that now more insurers, at first review, attempt to exclude PPL coverage for opioids. When pushed, the PPL underwriters will negotiate some minimal coverages, but only with specific controls, risk minimization and carve-out limits.

Hopefully, the unscrupulous maverick distributors and dispensers will get priced out of the opioid market.

Doing better requires constant vigilance and aggressive pharmaceutical reviews.

Call us. We can do better.

William Faris, JD
Chief Executive Officer
502-495-5040
william.faris@omca.biz
www.omca.biz

Posted in News